Avid Bioservices Inc (CDMO)

[Bamboozler762]

I too would like it if someone could further explain the patents that PPHM has on PS targeting and how far it reaches. Last month this same PS targeting nanovesicles tech was mention in a link that someone's posted here relating to PS targeting.

This is the first company (Bexion Pharmaceuticals, private company) that I've read about who is also targeting PS with their drug tech (SapC-DOPS (BXQ-350)), both for cancer killing and imaging. As far as I can see they have not yet confirmed to have started a phase I trial.

I have read here that PPHM 'has a lock' on PS targeting, but what is the reach (just first to trials with a PS targeting app)? I'm assuming with another PS targeting drug in very early development (BXQ-350) that PPHM's patents do not cover the targeting of PS itself, but rather the methods of action for killing and or imaging, or am I wrong? Any high level overview regarding what their patents (US and Euro) exclusively entitles Bavi to is appreciated.

(first post and all, long PPHM since earlier this year, don't much care if it takes 2+ years for this guy to go, the tech is solid, repeat (and more than likely improve) phase II results and it will fly (and with it any investment dropped into it now))